Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children

Pediatric Infectious Disease Journal

Volumn 25, Issue 10, 2006, Pages 912-919

  Guerra, Fernando A ^a   Gress, Jacqueline ^b   Werzberger, Alan ^c   Reisinger, Keith ^d   Walter, Emmanuel ^e   Lakkis, Hassan ^b   Grosso, Anthony D ^b   Welebob, Carolee ^b   Kuter, Barbara J ^b   Block, Stan ^f   Chartrand, Stephen ^f   Chatterjee, Archana ^f   Santosham, Mathuram ^f   Blumberg, Dean ^f   Taylor, James A ^f   Keyserling, Harry ^f   Sperling, Malcolm J ^f   Bocchini, Joseph ^f   Murphey, Donald ^f   Bostrum, Samantha ^f   Gooch, W Malcolm ^f   more..

^a San Antonio Metropolitan Health District   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Kiryas Joel Medical Research Institute   (United States)

^d Pittsburgh Environ Res Lab Inc   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f NONE

Author keywords

Hepatitis A vaccine; Immunization; Immunogenic; Pediatric vaccines

Indexed keywords

ACELLULAR VACCINE; CHICKENPOX VACCINE; DIPHTHERIA VACCINE; HEPATITIS A VACCINE; INACTIVATED VACCINE; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; TETANUS TOXOID;

ACIDOSIS; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ASTHMA; BRONCHIOLITIS; CHICKENPOX; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DIPHTHERIA; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEBRILE CONVULSION; FEMALE; FEVER; FOLLOW UP; FOREIGN BODY; GASTROENTERITIS; HEPATITIS A; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFANT; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SWELLING; IRRITABILITY; LARYNGOTRACHEOBRONCHITIS; MALE; MEASLES; MUMPS; NORMAL HUMAN; OTITIS MEDIA; PERTUSSIS; PNEUMONIA; POLIOMYELITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; RUBELLA; SEROLOGY; SIDE EFFECT; TETANUS; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VOMITING;

ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; CHICKENPOX VACCINE; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOENZYME TECHNIQUES; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL;

EID: 33749453789     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000238135.01287.b9     Document Type: Article

References (20)

1. Armstrong GA, Bell BP. Hepatitis A virus infections in the United States: Model-based estimates and implications for childhood immunization. Pediatrics. 2002;109:839-845.
2. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 1999;48:1-37.
3. Lednar WM, Lemon SM, Kirkpatrick JW, Redfield RR, Fields ML, Kelley PW. Frequency of illness associated with epidemic hepatitis A virus infection in adults. Am J Epidemiol. 1985;122:226-233.
4. Staes CJ, Schlenker TL, Risk I, et al. Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics. 2000;106:e54.
5. Hadler SC, Webster HM, Erben JJ, Swanson JE, Maynard JE. Hepatitis A in day-care centers: A community wide assessment. N Engl J Med. 1980;302:1222-1227.
6. Hadler SC, McFarland L. Hepatitis in day care centers: Epidemiology and prevention. Rev Infect Dis. 1986;8:548-557.
7. Lieberman JM, Marcy SM, Partridge S, Ward JI. Evaluation of a hepatitis A vaccine in infants: Effect of maternal antibodies on the antibody response. In: 36th Annual Meeting of the Infectious Diseases Society of America; Denver, CO; 1998.
8. Lieberman JM, Chang SJ, Partridge S, et al. The kinetics of maternal hepatitis A antibody decay: Implications for vaccine use in infants. Pediatr Infect Dis J. 2002;21:347-348.
9. Shehab ZM, Brunell PA, Cobb E. Epidemiological standardization of a test for susceptibility to mumps. J Infect Dis. 1984;149:810-812.
10. Wasmuth EH, Miller WJ. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen. J Med Virol. 1990;32:189-193.
11. Provost PJ, Krah DL, Kuter BJ, et al. Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine. 1991;9:111-116.
12. Collett D. Modeling Binary Data. London: Chapman and Hall; 1991.
13. Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med. 1985;4:213-226.
14. Pichichero MF, Francis AB, Marsocci SM, Green JL, Disney FA, Meschievitz C. Safety and immunogenicity of an acellular pertussis vaccine booster in 15- to 20-month-old children previously immunized with acellular or whole-cell pertussis vaccine as infants. Pediatrics. 1993;91:756-760.
15. Bernstein DI, Smith VE, Schiff GM, Rathfon HM, Boscia JA. Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age. Pediatr Infect Dis J. 1993;12:131-135.
16. Edwards KM, Meade BD, Decker MD, et al. Comparison of 13 acellular pertussis vaccines: Overview and serologic response [published erratum appears in Pediatrics. 1996;97:784]. Pediatrics. 1995;96:548-557.
17. Pichichero ME, Deloria MA, Rennels MB, et al. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pediatrics. 1997;100:772-778.
18. Halperin SA, Eastwood BJ, Barreto L, et al. Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life. Vaccine. 1996;14:767-772.
19. Dagan R, Amir J, Mijalovsky A, et al. Immunization against hepatitis A in the first year of life: Priming despite the presence of maternal antibody. Pediatr Infect Dis J. 2000;19:1045-1052.
20. Letson GW, Shapiro CN, Kuehn D, et al. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants. J Pediatr. 2004;144:327-332.